AbbVie Inc.ABBVNYSE
LOADING
|||
R&D Expense Growth Accelerating
Trending higher, above historical average, modest growth trend.
Left:
||||
Year-over-year research & development expense growth
Latest
66.66%
↑ 220% above average
Average (9y)
20.84%
Historical baseline
Range
High:115.84%
Low:-36.84%
CAGR
+9.3%
Consistent expansion
| Period | Value |
|---|---|
| 2024 | 66.66% |
| 2023 | 17.90% |
| 2022 | -19.09% |
| 2021 | 3.75% |
| 2020 | 14.18% |
| 2019 | -36.84% |
| 2018 | 115.84% |
| 2017 | 14.11% |
| 2016 | 1.89% |
| 2015 | 29.97% |